Skip to main content

Stereotaxis, Inc.

corporate_fare Company Profile

Stereotaxis, Inc.

STXS·NYSE·Industrial Applications And Services·CIK 0001289340

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include Genesis RMN, which enables physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites, and the GenesisX RMN System, designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. The company also offers Odyssey, a Synchrony and SynX Solution providing an integrated, real-time information solution to manage, control, record and share procedures across networks, as well as x-ray systems. In addition, Stereotaxis offers disposables and other accessories, including the MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. It further provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. Products are marketed through a direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Stereotaxis, Inc. (NYSE:STXS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 3 items for STXS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for STXS spans 10-Q, SCHEDULE 13D/A, 8-K.

Recent high-impact activity:

  • Stereotaxis Q3 Revenue Up 20% but Gross Margin Slides to 44%; Cash Falls to $4.0M
  • DAFNA Buys $2M of 10% Convertible Notes, Discloses 15.3% Stereotaxis Stake
  • Stereotaxis Raises $12M Now, Up to $24M Total, in 10% Convertible Notes at $1.21

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$32.38M
Net Income
-$21.64M
Diluted EPS
-$0.25
Op. Cash Flow
-$13.69M
Free Cash Flow
-$13.78M
Gross Profit
$17.07M
Operating Income
-$22.11M
Cash & Equivalents
$13.42M
Debt / Equity
0.00×
Net Margin
-66.8%
Shares Outstanding
90.96M sh
Source: 10-K · filed 2026-04-03 · accession 0001493152-26-015172

Short Interest & Short Volume

8.40 days to cover

FINRA reported short interest of 5,556,001 shares in STXS as of the October 30, 2026 settlement, a 7.3% decrease from the prior period — about 8.4 days to cover at its recent average daily volume. On November 20, 2026, 79.5% of STXS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)5,556,001 shares as of October 30, 2026
Change vs prior period▼ 7.3%
Days to cover8.40 at avg daily volume of 661,224
Daily short volume (FINRA facilities)79.5% of 767,556 shares on November 20, 2026
5-day average short volume77.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$0.961 +2.00% today
52-week range · as of 2026-11-16 $0.80 – $2.86
Market cap
$95.03M
Volume
1.3M (1.3× avg)
3-mo avg 950.8K
Live data · 2026-11-21 23:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed STXS - Latest Insights

STXS
Nov 16, 2026, 12:27 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.8535
Real-time Price: $0.961 info
Change: +$0.1075 (+13%) info
Market Cap: $95.026M info
STXS
Nov 12, 2026, 5:00 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.8653
Real-time Price: $0.961 info
Change: +$0.0957 (+11%) info
Market Cap: $95.026M info
STXS
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8685
Real-time Price: $0.961 info
Change: +$0.0925 (+11%) info
Market Cap: $95.026M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets